Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Eleanor Stride (Department of Engineering Science and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science) has taken an unconventional path to becoming one of Britain’s leading scientists. In a new Oxford Science Blog, she tells Sarah Whitebloom how she moved from dance to design and onto biomedical science, but being a 'woman in science' is not one of the identities she seeks.

Professor Eleanor Stride © New York Academy of Sciences/ Blavatnik Awards for Young Scientists

When is a woman in science not a ‘woman in science’? When she is a woman in science.

At the risk of generalisation, women in science are hard-working, dedicated, cutting edge…scientists.  Call them ‘women in science’ at your peril.  Women in science will tell you quite firmly that they do not want to be treated differently or feel they do not deserve their place. Any hint of tokenism will be greeted with a frosty response. 

And Professor Eleanor Stride is an uber scientist, which is nothing to do with mini-cabs but everything to do with dedication, hard-work and world-changing ideas.  It is hard to imagine that she has ever felt she is making up the numbers.

‘You’d be surprised,’ she says. Sometimes, it is felt that there has to be a woman involved and no one wants to be that woman.  Professor Stride maintains there is, of course, a need for more women in science and is infuriated at the idea that girls are still told that Maths and science is not for them. She is, quite literally, furious at the ‘Mummy wasn’t any good at Maths’, sort of parental advice. And, she says, the counter-balance needs to start early, at Primary School, when girls start to drift away from the sciences and Maths.

Read the full blog on the University of Oxford website

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.